. . . . . . . . . .

“Abstract submission for the congress was closed

in 30th Nov. 2016.”

Abstract Submission Form

 

.

Instruction for Abstract Submission

The abstract text should be in English language and limited to 500 words.

The final decision on the acceptance of the abstracts for presentation as oral/poster will be sent to the registered email address within a month (10th Dec.2016)

We have provided an electronic form for abstract submission in which you can view and review the information you have entered before final submission.

In the bottom of the form you need to upload the abstract file. This file should be in Microsoft Word format and font “Times New Roman size 12 (Regular)” and should include the following sections respectively in two options:

Abstract Structure

The Congress offers two options for abstract submission:

Option 1
Suited for research conducted in all disciplines. Abstracts submitted under the first option should contain concise statements of:

  • Background: indicate the purpose and objective of the research, the hypothesis that was tested or a description of the problem being analyzed or evaluated.
  • Methods: describe the study period / setting / location, study design, study population, data collection and methods of analysis used.
  • Results: present as clearly and in as much detail as possible the findings / outcome of the study. Please summarize any specific results.
  • Conclusions: explain the significance of your findings / outcomes of the study for cancer prevention and early detection.

The following review criteria will be used in scoring abstracts submitted under option 1:

  1. Is there a clear background and justified objective?
  2. Is the methodology/study design appropriate for the objectives?
  3. Are the results important and clearly presented?
  4. Are the conclusions supported by the results?
  5. Is the study original, and does it contribute to the field?

Option 2 
Suited for lessons learned through programme, project or policy implementation or management. Abstracts submitted under the second option should contain concise statements of:

  • Background: summarize the purpose, scope and objectives, of the programme, project or policy.
  • Description: describe the programme, project or policy period / setting / location, the structure, key population (if applicable), activities and interventions undertaken in support of the programme, project or policy.
  • Lessons learned: present as clearly and in as much detail as possible the findings / outcomes of the programme, project or policy; include an analysis or evaluation of lessons learned and best practices. Please summarize any specific results that support your lessons learned and best practices.
  • Conclusions/Next steps: explain the significance of your findings / outcomes of the programme, project or policy for cancer prevention and early detection.

The following review criteria will apply to abstracts submitted under option 2:

  1. Is there a clear background and justified objective?aim
  2. Is the programme, project or policy design and implementation appropriate for the objectives?
  3. Are the lessons learned or best practices important, supported by the findings and clearly presented?
  4. Are the conclusions/next steps supported by the results and are they feasible?
  5. Is the work reported original, and does it contribute to the field?

 

Abstract Publication

Accepted abstracts will be published in a special issue of “Archives of Iranian Medicine (AIM)”_ an ISI indexed Journal. www.aimjournal.ir

Notice: Abstract that published in other peer reviewed journal may be accepted only for the oral or poster presentation. However you need to revise or update it to fit the congress mission. We will not accept exact copy of the published paper. Pleased read the Policies for Abstract Submission & Declaration section.

After successful submitting an abstract, a success message will appear that contains a “tracking code”. You need to keep this code for future use. In this message you can find all the information you have provided and it is possible for you to print it.

 

Policies for Abstract Submission & Declaration
Copyright Policy

Abstracts should not include libelous or defamatory content. Material presented in abstracts should not violate any copyright laws. If figures/graphics/images have been taken from sources not copyrighted by the author, it is the author’s sole responsibility to secure the rights from the copyright holder in writing to reproduce those figures/graphics/images for both worldwide print and web publication. All reproduction costs charged by the copyright holder must be borne by the author.

Resubmission Policy

An abstract which has been previously published or presented at a national, regional or international meeting can only be submitted provided that there are new methods, new findings, updated information or other valid reasons for submitting that can be provided by the author.

If preliminary or partial data has been published or presented, the author is required to indicate the details of the publication or presentation as well as the reasons for submitting the abstract to this congress. This information will be considered by the Scientific Programme Committee when making final decisions.

If the author neglects to indicate the details of when and where the preliminary or partial data has been published or presented, and the reasons for resubmitting (new methods, new findings, substantially updated information or other valid reasons), and if evidence of previous publication or presentation is found, the abstract may be rejected.

Plagiarism

The conference organizers regard plagiarism as serious professional misconduct. All abstracts are screened for plagiarism and when identified, the abstract and any other abstracts submitted by the same author are rejected. In addition, the submitting author’s profile and scholarship application, in the case one has been submitted, will also be cancelled.

Ethical Research Declaration 

The conference supports only research that has been conducted according to the protocol approved by the institutional or local committee on ethics in human investigation. Where no such committee exists, the research should have been conducted in accordance with the principles of the Declaration of Helsinki of World Medical Association. The Congress Scientific Programme Committee may enquire further into ethical aspects when evaluating the abstracts.

 

Abstract Submission and Review Process

Conference Profile 

Choosing a Track Category

Set Font & Word Limits

Common reasons for abstract rejection:

  • Abstract poorly written
  • Not enough new information
  • Clear objective and/or hypothesis missing
  • Linkage between different parts of the abstract not comprehensible
  • Duplicate or overlap with another abstract
  • Study/project/programme/policy too preliminary or insufficient to draw conclusions
  • Study/project/programme/policy lack of originality

Reasons for abstract rejection – specific to Option 1:

  • Methods (either quantitative or qualitative) inadequate and/or insufficient to support conclusions
  • Summary of essential results inadequate and/or missing

Reasons for abstract rejection – specific to Option 2:

  • Description inadequate and/or insufficient to support conclusions
  • Lessons learned inadequate and/or missing

Recommendations

  • Abstracts should disclose primary findings and avoid, whenever possible, promissory statements such as “experiments are in progress” or “results/lessons learned will be discussed”.
  • If English is not your native language we recommend that you have your abstract reviewed by a native speaker before submission.

Submission Confirmation

After submission of the abstract, a confirmation email will be sent to the abstract submitter. In order to receive confirmation, please ensure that emails from crniran@gmail.com are not marked as spam by your e-mail provider.

 

Abstract Review and Selection Process
Abstract Review

All submitted abstracts will go through a blind peer-review process carried out by an reviewing committee. Each abstract will be reviewed by at least three reviewers.

Abstract Selection 

The Scientific Programme Committee makes the final selection of abstracts to be included in the conference programme. Abstracts can be selected for oral presentation in oral abstract sessions or to be presented as a poster. A small number of highest-scoring posters are selected for presentation in oral poster discussion sessions, whereas majority of the posters will be displayed in the Poster Exhibition.

Notification of Acceptance or Rejection to Corresponding Author 

Notification of acceptance or rejection will be sent to the submitting (corresponding) author by mid-April. Please note that only the corresponding author will receive mail concerning the abstract and is responsible for informing all co-authors of the status of the abstract. Authors whose abstracts have been accepted will receive instructions for the presentation of their abstract.

 

Questions

  • For questions regarding the abstract submission system, the content of the abstract please contact the abstract support team at crniran@gmail.com
Abstract Submission Form
. . . . . . . . . .